EyePoint Pharmaceuticals Inc’s recent filing unveils that its 10% Owner Cormorant Asset Management, LP acquired Company’s shares for reported $10.49
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
EyePoint Pharmaceuticals Inc’s recently made public that its 10% Owner Cormorant Asset Management, LP acquired Company’s shares for reported $10.49
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
EyePoint Pharmaceuticals Inc’s recently made public that its SVP & Chief Commercial Officer Jones David Scott unloaded Company’s shares for
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. EyePoint Pharmaceuticals
EyePoint Pharmaceuticals Inc’s filing revealed that its SVP & Chief Commercial Officer Jones David Scott unloaded Company’s shares for reported
The NASDAQ’s 1.0% gain led the market yesterday, and the S&P 500 and DJIA posted fractional gains. After passing its
The S&P 500 pulled back from its newly acquired all-time high yesterday and 0.4% on the session. The NASDAQ also